TARO — Taro Pharmaceutical Industries Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid Cap

Annual balance sheet for Taro Pharmaceutical Industries, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	20-F	20-F	20-F	20-F	6-K
Standards:	USG	USG	USG	USG	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,109	1,024	821	850	879
Net Total Accounts Receivable
Net Total Receivables	264	254	293	248	219
Total Inventory
Prepaid Expenses
Total Current Assets	1,533	1,471	1,338	1,336	1,303
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	212	208	205	194	218
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	2,341	2,407	2,176	2,136	2,162
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	223	676	432	386	361
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	237	703	465	405	369
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	2,104	1,704	1,711	1,731	1,793
Total Liabilities & Shareholders' Equity	2,341	2,407	2,176	2,136	2,162
Total Common Shares Outstanding